Evidence map›Paper›PMID 41146199›Full record

ArticleCancer cell international2025

Correction: Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Leiming Xia, Mengni Qu, Ling Ge, Yingying Chen, Beibei Zhou, Ting Shi, Yang Liu, Min Ruan, Liang Xia, Jian Hong and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Leiming Xia *Department of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China. 278461175@qq.com.
Mengni Qu *Department of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Ling Ge *Department of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Yingying Chen *Department of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Beibei ZhouDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Ting ShiDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Yang LiuDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Min RuanDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Liang XiaDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Jian HongDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Jianjun LiDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Wei QianDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Yu ZhangDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Lei JiangDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Yiming ZhaoDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Wanlu TianDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Zhenqi HuangDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China.
Fengbo JinDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China. 13855191690@163.com.
Jian GeDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China. gejian52@163.com.
Mingzhen YangDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China. yangmz89@163.com.
Qingshu ZengDepartment of Hematology , The First Affiliated Hospital of Anhui Medical University , Hefei, China. zengqingshu2014@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41146199
PMCPMC12557908

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.